183
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Progress towards the use of HIV proteases in cancer therapy

Pages 636-637 | Published online: 01 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Panagiota Papanagnou, Panagiotis Baltopoulos & Maria Tsironi. (2015) Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal. Therapeutics and Clinical Risk Management 11, pages 807-819.
Read now

Articles from other publishers (6)

Mahbuba R. Subeha & Carlos M. Telleria. (2020) The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir. Cancers 12:11, pages 3437.
Crossref
Tomas Koltai. (2015) Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity. F1000Research 4, pages 9.
Crossref
Reem Smoum, Abraham Rubinstein, Valery M. Dembitsky & Morris Srebnik. (2012) Boron Containing Compounds as Protease Inhibitors. Chemical Reviews 112:7, pages 4156-4220.
Crossref
Michelle Alonso-Basanta, Christina Chapman, Jay F. Dorsey, Ramesh Rengan & Stephen M. Hahn. (2011) A Glimpse of the Future. The Cancer Journal 17:3, pages 190-194.
Crossref
Supriya Krishnan, Jeffrey T. Schouten, Denise L. Jacobson, Constance A. Benson, Ann C. Collier, Susan L. Koletar, Jorge Santana, Fred R. Sattler & Ronald Mitsuyasu. (2011) Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis. Oncology 80:1-2, pages 42-49.
Crossref
Robert J. Danaher, Chunmei Wang, Andrew T. Roland, Charlotte S. Kaetzel, Richard N. Greenberg & Craig S. Miller. (2010) HIV protease inhibitors block oral epithelial cell DNA synthesis. Archives of Oral Biology 55:2, pages 95-100.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.